132 related articles for article (PubMed ID: 33859674)
21. Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades.
Ait Ssi S; Chraa D; El Azhary K; Sahraoui S; Olive D; Badou A
Front Immunol; 2021; 12():685213. PubMed ID: 34539626
[TBL] [Abstract][Full Text] [Related]
22. EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study.
Hao Z; Guo D
BMC Cancer; 2019 Dec; 19(1):1184. PubMed ID: 31801484
[TBL] [Abstract][Full Text] [Related]
23. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
24. Elevated expression of DOK3 indicates high suppressive immune cell infiltration and unfavorable prognosis of gliomas.
Liu X; Chen F; Li W
Int Immunopharmacol; 2020 Jun; 83():106400. PubMed ID: 32193105
[TBL] [Abstract][Full Text] [Related]
25. Bioinformatics analysis of the prognostic value of NEK8 and its effects on immune cell infiltration in glioma.
Xiao M; Du C; Zhang C; Zhang X; Li S; Zhang D; Jia W
J Cell Mol Med; 2021 Sep; 25(18):8748-8763. PubMed ID: 34374193
[TBL] [Abstract][Full Text] [Related]
26. Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma.
Zhou Q; Zhou J; Fan J
Front Oncol; 2021; 11():638803. PubMed ID: 34094918
[TBL] [Abstract][Full Text] [Related]
27. CKMT1B is a potential prognostic biomarker and associated with immune infiltration in Lower-grade glioma.
Shi H; Song Y; Song Z; Huang C
PLoS One; 2021; 16(1):e0245524. PubMed ID: 33465115
[TBL] [Abstract][Full Text] [Related]
28. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
29. New prognostic biomarker
Li S; Gao P; Dai X; Ye L; Wang Z; Cheng H
Ann Transl Med; 2022 Feb; 10(4):206. PubMed ID: 35280380
[TBL] [Abstract][Full Text] [Related]
30. NCAPG as a Novel Prognostic Biomarker in Glioma.
Jiang X; Shi Y; Chen X; Xu H; Liu B; Zhou F; Huang X; Cho WC; Li L; Pu J
Front Oncol; 2022; 12():831438. PubMed ID: 35280743
[TBL] [Abstract][Full Text] [Related]
31. High Levels of HIST1H2BK in Low-Grade Glioma Predicts Poor Prognosis: A Study Using CGGA and TCGA Data.
Liu W; Xu Z; Zhou J; Xing S; Li Z; Gao X; Feng S; Xiao Y
Front Oncol; 2020; 10():627. PubMed ID: 32457836
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients.
Liu B; Liu Z; Wang Y; Lian X; Han Z; Cheng X; Zhu Y; Liu R; Zhao Y; Gao Y
Mol Med; 2021 Sep; 27(1):117. PubMed ID: 34556022
[TBL] [Abstract][Full Text] [Related]
33. The GAR domain of GAS2L3 mediates binding to the chromosomal passenger complex and is required for localization of GAS2L3 to the constriction zone during abscission.
Fackler M; Wolter P; Gaubatz S
FEBS J; 2014 May; 281(9):2123-35. PubMed ID: 24571573
[TBL] [Abstract][Full Text] [Related]
34.
Liu B; Su Q; Xiao B; Zheng G; Zhang L; Yin J; Wang L; Che F; Heng X
Front Oncol; 2021; 11():657029. PubMed ID: 34912698
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatics analysis of C3 in brain low-grade gliomas as potential therapeutic target and promoting immune cell infiltration.
Wu S; Miao K; Wang L; Ma Y; Wu X
Med Oncol; 2022 Jan; 39(2):27. PubMed ID: 35018510
[TBL] [Abstract][Full Text] [Related]
36. Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells.
Liu Z; Wang H; Jia Y; Wang J; Wang Y; Bian L; Liu B; Lian X; Zhang B; Ren Z; Zhang W; Dai W; Gao Y
Cancer Med; 2021 Aug; 10(15):5218-5234. PubMed ID: 34264013
[TBL] [Abstract][Full Text] [Related]
37. Gas2l3, a novel constriction site-associated protein whose regulation is mediated by the APC/C Cdh1 complex.
Pe'er T; Lahmi R; Sharaby Y; Chorni E; Noach M; Vecsler M; Zlotorynski E; Steen H; Steen JA; Tzur A
PLoS One; 2013; 8(2):e57532. PubMed ID: 23469016
[TBL] [Abstract][Full Text] [Related]
38. CDK5 Knockdown inhibits proliferation and induces apoptosis and Cell Cycle Arrest in Human Glioblastoma.
Zhou Y; Wang X; Lv P; Yu H; Jiang X
J Cancer; 2021; 12(13):3958-3966. PubMed ID: 34093802
[No Abstract] [Full Text] [Related]
39.
Hu Z; Qu S
Front Immunol; 2021; 12():683572. PubMed ID: 34267752
[TBL] [Abstract][Full Text] [Related]
40. RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas.
Zhao X; Wang Y; Li J; Qu F; Fu X; Liu S; Wang X; Xie Y; Zhang X
Sci Rep; 2022 Feb; 12(1):3122. PubMed ID: 35210438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]